-
1
-
-
0032818533
-
In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenern antibiotic with potent antipneumococcal activity
-
Hikida M, Itahashi K, Igarashi A, Shiba T, Kitamura M: In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenern antibiotic with potent antipneumococcal activity. Antimicrob Agents Chemother 1999; 43: 2010-6
-
(1999)
Antimicrob Agents Chemother
, vol.43
, pp. 2010-2016
-
-
Hikida, M.1
Itahashi, K.2
Igarashi, A.3
Shiba, T.4
Kitamura, M.5
-
2
-
-
0035170349
-
In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections
-
Miyazaki S, Hosoyama T, Furuya N, Ishii Y, Matsumoto T, Ohno A, et al: In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections. Antimicrob Agents Chemother 2001; 45: 203-7
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 203-207
-
-
Miyazaki, S.1
Hosoyama, T.2
Furuya, N.3
Ishii, Y.4
Matsumoto, T.5
Ohno, A.6
-
3
-
-
14744268018
-
In vitro activity of tebipenem, a new oral carbapenem antibiotic, against penicillin-nonsusceptible Streptococcus pneumoniae
-
Kobayashi R, Konomi M, Hasegawa K, Morozumi M, Sunakawa K, Ubukata K: In vitro activity of tebipenem, a new oral carbapenem antibiotic, against penicillin-nonsusceptible Streptococcus pneumoniae. Antimicrob Agents Chemother 2005; 49: 889-94
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 889-894
-
-
Kobayashi, R.1
Konomi, M.2
Hasegawa, K.3
Morozumi, M.4
Sunakawa, K.5
Ubukata, K.6
-
4
-
-
3042797680
-
Methods for antimicrobial susceptibility testing of anaerobic bacteria
-
National Committee for Clinical Laboratory Standards:, 3rd ed, National Committee for Clinical Laboratory Standards, Villanova, PA
-
National Committee for Clinical Laboratory Standards: Methods for antimicrobial susceptibility testing of anaerobic bacteria, 3rd ed. Approved standard NCCLS document M11-A3. National Committee for Clinical Laboratory Standards, Villanova, PA. 1993
-
(1993)
Approved standard NCCLS document
-
-
-
5
-
-
65249110460
-
-
Japanese source.
-
Japanese source.
-
-
-
-
6
-
-
0025000285
-
R-plasmid mediated transfer of β-lactam resistance in Bacteroides fragilis
-
Yamaoka K, Watanabe K, Muto Y, Katoh N, Ueno K, Tally F P: R-plasmid mediated transfer of β-lactam resistance in Bacteroides fragilis. J Antibiot 1990; 43: 1302-6
-
(1990)
J Antibiot
, vol.43
, pp. 1302-1306
-
-
Yamaoka, K.1
Watanabe, K.2
Muto, Y.3
Katoh, N.4
Ueno, K.5
Tally, F.P.6
-
7
-
-
0003112431
-
Antibiotic inactivating enzymes and bacterial resistance
-
Lorian V ed, 2nd ed. Williams & Wilkins Co
-
Neu H C: Antibiotic inactivating enzymes and bacterial resistance. In Lorian V (ed.), Antibiotics in laboratory medicine, 2nd ed. Williams & Wilkins Co. 1986; p. 757-89
-
(1986)
Antibiotics in laboratory medicine
, pp. 757-789
-
-
Neu, H.C.1
-
8
-
-
0026520788
-
Conjugal transfer of imipenem resistance in Bacteroides fragilis
-
Bandoh K, Watanabe K, Muto Y, Tanaka Y, Kato N, Ueno K: Conjugal transfer of imipenem resistance in Bacteroides fragilis. J Antibiot 1992; 45: 542-7
-
(1992)
J Antibiot
, vol.45
, pp. 542-547
-
-
Bandoh, K.1
Watanabe, K.2
Muto, Y.3
Tanaka, Y.4
Kato, N.5
Ueno, K.6
-
9
-
-
0001862166
-
Anaerobic infections in humans: An overview
-
Finegold S M: Anaerobic infections in humans: an overview. Anaerobe 1995; 1: 3-9
-
(1995)
Anaerobe
, vol.1
, pp. 3-9
-
-
Finegold, S.M.1
-
10
-
-
65249144585
-
-
Japanese source.
-
Japanese source.
-
-
-
-
11
-
-
0033141244
-
Antimicrobial susceptibility and β-lactamase production of Prevotella spp. and Porphyromonas spp
-
Tanaka K, Kawamura C, Fukui K, Kato H, Kato N, Nakamura T, et al: Antimicrobial susceptibility and β-lactamase production of Prevotella spp. and Porphyromonas spp. Anaerobe 1999; 5: 461-3
-
(1999)
Anaerobe
, vol.5
, pp. 461-463
-
-
Tanaka, K.1
Kawamura, C.2
Fukui, K.3
Kato, H.4
Kato, N.5
Nakamura, T.6
|